ANI Pharmaceuticals

In two facilities with combined manufacturing, packaging and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. The fully-cGMP qualified facilities boast state-of-the-art analytical and stability laboratories for ANI's rapidly expanding research and development program. With several ANDAs pending FDA approval, and in various stages of development, ANI is poised for tremendous growth in the months and years to come!
Type
Public
HQ
Baudette, US
Employees
108 (est)
ANI Pharmaceuticals is headquartered in Baudette, US

ANI Pharmaceuticals Locations

Baudette, US
Baudette, US

ANI Pharmaceuticals Metrics

ANI Pharmaceuticals Summary

Market capitalization

$651 M

Closing share price

$56.8
ANI Pharmaceuticals's current market capitalization is $651 M.

ANI Pharmaceuticals Financials

ANI Pharmaceuticals's revenue is $76.3 M in FY, 2015 which is 36.36% increase from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$30.1 M$56 M$76.3 M

Gross profit

$20.1 M$44.5 M$63.6 M

Operating income

$898 K$20 M$32.7 M

Operating expense total

$19.2 M$24.5 M$30.9 M

Net Income

$301 K$28.7 M$15.4 M

Operating cash flow

$11.1 M$158 M$-14.4 M

    ANI Pharmaceuticals Market Value History

    ANI Pharmaceuticals News

    ANI Pharmaceuticals Company Life

    You may also be interested in